Singh Mahendra, Sagili Karuna D, Tripathy Jaya P, Kishore Surekha, Bahurupi Yogesh A, Kumar Ajay, Kala Vagish, Yadav Vikas, Murmu Shikha
Department of Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Department of TB and Communicable Diseases, The Union South East Asia Office, New Delhi, India.
J Glob Infect Dis. 2020 Feb 19;12(1):28-33. doi: 10.4103/jgid.jgid_66_19. eCollection 2020 Jan-Mar.
India has adopted active case finding (ACF) as an additional strategy to find its missing tuberculosis (TB) cases since 2017. Treatment outcomes of patients identified through ACF may be similar or different from those detected through routine passive case finding (PCF); currently, there are limited studies on this in India.
The aim of this study was to assess differences in treatment outcomes of patients detected through ACF and PCF under the national TB program.
A study was conducted in six TB units of Haridwar district where ACF campaigns were conducted in 2017-2018.
Data from patients detected by ACF ( = 72) and PCF ( = 184) were extracted from program records.
Of 72 patients detected by ACF, only 54 (75%) were initiated on treatment. A high proportion of initial loss to follow-up (25% vs. 0%) and delay in treatment initiation (4 days vs. 0 days) was observed in ACF patients as compared to PCF. The proportion of unsuccessful treatment outcome was 33% ( = 18) among ACF patients compared to 14% ( = 25) among PCF patients (adjusted relative risk: 2.6, 95% confidence interval: 1.7-4.0).
High initial loss to follow-up, delay in treatment initiation, and poor treatment outcome among ACF patients are a major concern. The study results call for active follow-up after diagnosis and close monitoring during treatment for patients detected by ACF.
自2017年以来,印度已采用主动病例发现(ACF)作为寻找其漏报结核病(TB)病例的补充策略。通过ACF发现的患者的治疗结果可能与通过常规被动病例发现(PCF)发现的患者相似或不同;目前,印度对此的研究有限。
本研究的目的是评估在国家结核病规划下通过ACF和PCF发现的患者在治疗结果上的差异。
在哈里德瓦尔区的六个结核病治疗单位进行了一项研究,2017 - 2018年在这些单位开展了ACF活动。
从项目记录中提取通过ACF(n = 72)和PCF(n = 184)发现的患者的数据。
在通过ACF发现的72例患者中,只有54例(75%)开始接受治疗。与PCF患者相比,ACF患者中初始失访比例较高(25%对0%),治疗开始延迟时间较长(4天对0天)。ACF患者中治疗结果未成功的比例为33%(n = 18),而PCF患者中这一比例为14%(n = 25)(调整后的相对风险:2.6,95%置信区间:1.7 - 4.0)。
ACF患者中高初始失访率、治疗开始延迟和治疗结果不佳是一个主要问题。研究结果呼吁对ACF发现的患者在诊断后进行积极随访,并在治疗期间进行密切监测。